Prelude Capital Management’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,500
Closed -$12K 1596
2022
Q3
$12K Buy
+16,500
New +$197K ﹤0.01% 1304

Other funds holding SRTS

Prelude Capital Management's SRTS Position: Q2 2025 in Review

Prelude Capital Management sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 11,986 shares — an estimated $56.7K sold.

Prelude Capital Management first reported a position in SRTS in Q3 2022 and held it in 5 quarters. The position peaked at $423K in Q3 2022. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

  • Prelude Capital Management reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 11,986 Sensus Healthcare shares in Q2 2025, an estimated $56.7K.
  • Prelude Capital Management first reported a position in Sensus Healthcare in Q3 2022 and held it in 5 quarters.
  • Prelude Capital Management's Sensus Healthcare position peaked at $423K in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.